Skip to main content
Bellicum Pharmaceuticals, Inc.Portfolio

Bellicum Pharmaceuticals, Inc.: Bellicum Announces Interim Results Showing Rimiducid Controlled GvHD in Patients Treated with Rivo-cel Following a Stem Cell Transplant

By December 1, 2018March 9th, 2021No Comments